8 December 2017: NCOH Science Cafe
Save the date: December 8, 2017 NCOH Science Café
27 June: deadline of the NACTAR call
NACTAR stands for Novel Antibacterial Compounds and Therapies Antagonizing Resistance. This research programme on the development of new antibiotics and alternatives is commissioned by the Dutch Ministry of Health, Welfare and Sport and NWO-domain TTW and connects to the National Antibiotic Development Platform (NADP). An information event is organised on 7 June, deadline for the pre-proposals is 27 June.
More information and the call text can be found on the NWO-TTW-website.
20 June 2017: First annual symposium of NCOH
The first Annual Scientific Meeting of the Netherlands Centre for One Health (NCOH) will be held on 20 June. The meeting is aimed at researchers from our Partners and Associates that are involved in all the NCOH Strategic Research Themes. The theme of this symposium is “Global Solutions to One Health”. Prevention and control of infectious diseases outbreaks are important societal challenges, that require an integrated and balanced perspective in which human, veterinary, wildlife, and environmental elements and considerations are integrated. This One Health perspective will be the overarching subject of the annual meeting.
18 April 2017: Launch even NADP
This week the National Antibiotic Development Platform, NADP, was officially launched via a meeting in Utrecht, with many of the stakeholders in the field present. NADP facilitates the collaboration between public and private organizations, to enhance the development of new antibiotics and alternative therapies for infectious diseases in humans and animals. The NADP aims to fill the gap by matching partners and thereby help setting up public-private partnerships and was set up with support from the Ministry of Health (VWS). The Leiden Centre for Antimicrobial Research (CARES), the Groningen Center for Sustainable Antimicrobials (CeSAM), the Netherlands Centre for One Health (NCOH) and Immunovalley collaborate within the platform.
Friday 4 November 2016, 15.30 - 17.00: ONE HEALTH Science Café
We invite all NCOH investigators to come to the second ONE HEALTH Science Café to get up to speed with the latest developments and meet fellow NCOH colleagues.
Location: Collegezaal Gezelschapsdieren, faculteit Diergeneeskunde, Universiteit Utrecht, Münsterlaan, Utrecht
Programme: please view online
Registration: via this link
14 October 2016: NCOH-AMR symposium
On Friday October 14, 2016, the NCOH-AMR symposium will take place in Amsterdam, with an exciting program. In addition to the researchers already involved in NCOH-AMR, the symposium is also open for PhD students and other interested researchers. We kindly ask you to register for the meeting as the number of participants is limited. Participation is first-come, first-served. Please register here.
7 October 2016: Publication on soil (in Dutch)
In deze publicatie van Stichting Biowetenschappen en Maatschappij over de bodem, is een bijdrage van Gilles van Wezel opgenomen over antibiotica uit grondbacterien. Het boekje is gratis te downloaden.
30 September 2016: Interview with Gilles van Wezel (in Dutch)
Minister Edith Schippers van Volksgezondheid investeert de komende vier jaar ruim 6 miljoen in onderzoek naar nieuwe antibiotica. Het programma wordt opgezet door diverse partijen, waaronder CARES. Gilles van Wezel, hoogleraar Moleculaire Biotechnologie van het Instituut voor Biologie, licht toe hij hij zich samen met anderen vanaf het begin sterk heeft gemaakt om het nieuwe onderzoeksprogramma op te zetten.
22 September 2016: Gilles van Wezel in EditieNL
EditieNL, a Dutch news programme, made an item on novel antibiotics, where Gilles van Wezel and his PhD students Lizah van der Aart and Helga van der Heul explain how novel antimicrobials can be found (in Dutch).
September 2016: Minster Schippers invests 6 million Euro in new antibiotics
The Dutch Minister of Health, Welfare and Sport, Edith Schippers, will invest more than 6 million euros in research into new antibiotics during the next four years. The money is intended for a new research programme for the development of antibiotics and is associated with the new National Antibiotic Development Platform. The national research platform will facilitate new collaborations between relevant knowledge institutions and companies who are working on the development of new antibiotics and alternatives. The most important partners are the Netherlands Centre for One Health, CARES in Leiden, the Centre for Sustainable Antimicrobials in Groningen, and Immuno Valley (link to Dutch press release).
September 2016: Leiden and LUMC join NCOH
Leiden University and Leiden University Medical Center have joined the Netherlands Centre for One Health (NCOH), further strengthening the academic network in which such problems as antimicrobial resistance are studied (link to press release).
July 2016: Antibiotics in National Geographic NL
Gilles van Wezel was interviewed about AMR and finding novel antibiotics for National Geographic.
31 May 2016: Colistin-resistance gene mcr-1 detected in the USA
A plasmid-based mcr-1 gene, which makes bacteria resistant to the last-resort antibiotic colistin, was first described in China. The US Centre for Disease Control announced today that the first mcr-1 gene in E. coli bacteria was found in a human in the United States. The CDC states: "The presence of the mcr-1 gene, and its ability to share its colistin resistance with other bacteria such as CRE raise the risk that pan-resistant bacteria could develop."
5 February 2016: Minister of Health announces 16 M€ for antibiotics research
At the official opening of the NCOH, the Netherlands Centre for One Health, Edith Schippers, the Minister of Health, announced 16 M€ for antibiotics research. On 8 February, the fist call for projects is open.
4 February 2016: Antibiotics in "De Kennis van Nu"
27 January 2016: Nature commentary on antibiotics discovery
How to (re)fill the antibiotic pipelines with novel lead compounds? Gilles van Wezel and Roberto Kolter wrote a commentary on approaches in antibiotic discovery in Nature Microbiology.